Daily BriefsIndia

Daily Brief India: Doms, Mankind Pharma, Whirlpool of India and more

In today’s briefing:

  • DOMS Industries Ltd IPO- Forensic Analysis
  • Mankind Pharma Placement – Its Expensive, but at Least It’s High Quality
  • [Week 13] Namaste India 🙏 | Whirlpool’s Tax Woes
  • DOMS Industries IPO – Thoughts on Valuation – Isn’t Cheap, Neither Are Its Peers Cheap


DOMS Industries Ltd IPO- Forensic Analysis

By Nitin Mangal

  • Doms (DOMS IN) IPO opens for subscription soon. The INR 12 bn IPO includes INR 3.5 bn fresh issue and the remaining as offer for sale. 
  • The company is a prominent player in the Indian stationary market and has one of the most diverse product portfolio with a market share of 12% in F23. 
  • DOMS ticks right in majority of the boxes when it comes to operations and B/S health. One must still be cautious regarding dependence on FILA group, and faster depreciating rates.  

Mankind Pharma Placement – Its Expensive, but at Least It’s High Quality

By Sumeet Singh

  • A group of shareholders is looking to raise around US$600m via selling a 6.9% stake in Mankind Pharma.
  • MP is a pharmaceutical company engaged in developing, manufacturing and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
  • We have looked at the IPO and lock-up release earlier. In this note, we talk about the other deal dynamics.

[Week 13] Namaste India 🙏 | Whirlpool’s Tax Woes

By Pranav Bhavsar


DOMS Industries IPO – Thoughts on Valuation – Isn’t Cheap, Neither Are Its Peers Cheap

By Sumeet Singh

  • Doms (DOMS IN) is looking to raise around US$140m in its India IPO.
  • DOMS is a leading player and brand in India’s stationery and art products market. It designs, manufactures, and sells a wide range of products, primarily under its flagship brand ‘DOMS’.
  • We have looked at the company’s past performance in our earlier note. In this note, we talk about valuations.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars